Inside GSK's Health Care Revolution

Leadership Transition at GSK

• 💡 Emma Walmsley is stepping down as CEO of GSK after nine years, aiming to leave the company in a stronger position and ensure a seamless succession.
• 🚀 She is proud of the company's progress and the appointment of Luke Miles as her successor, whom she believes is the right person to lead GSK's next decade.

GSK's Strategic Transformation

• 📈 Under Walmsley's leadership, GSK underwent a major de-merger of its consumer healthcare business, the largest in Europe this century, which reset its balance sheet.
• ✅ This allowed for a doubling of R&D investment, leading to significant revenue growth from $20 billion to over $30 billion, with an outlook to exceed $40 billion.
• 🔬 GSK now has 15 major medicines and vaccines in its pipeline, with renewed momentum in oncology, respiratory, HIV, infectious diseases, and vaccines.

Innovation and US Healthcare Engagement

• 🇺🇸 GSK has made a deliberate choice to invest heavily in the US, recognizing it as a global superpower for healthcare innovation, with 52% of its sales coming from the US.
• 🤝 The company is constructively engaged with the US administration, agreeing on the need for healthcare system reform to improve access and affordability, despite drug pricing being only 14% of total costs.
• 💡 Walmsley emphasizes that innovation is key to reducing healthcare costs by preventing disease and promoting wellness, rather than just treating sickness.

The Critical Role of Vaccines

• 🛡️ Vaccines are highlighted as an important business segment for GSK, offering the best return on investment by stopping disease before it starts.
• 📊 Historical data from the CDC shows that pediatric vaccination has prevented 500 million cases of disease and over a million childhood deaths over 30 years.
• 💬 As a manufacturer, GSK aims to combat misinformation about vaccines with transparency, science, and data, collaborating with governments to answer reasonable questions.

Purpose and Leadership Philosophy

• 🎯 Walmsley stresses that purpose and values are the fundamental rock for difficult decisions, articulating GSK's purpose as "to get ahead of disease together."
• 🤝 The company's values include being ambitious for patients, accountable for impact, and doing the right thing with integrity and care.
• 🧠 She believes the CEO role requires resilience and stamina, emphasizing that it's not about being a "superhero" but about serving the team, company, and people.